INFLECTRA
infliximab-dyyb
TNF blocker biosimilar to infliximab used for moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Form
Injectable
Uses
3
Side effects
4
Category
Immunosuppressants
What is INFLECTRA used for?
- Treatment of moderately to severely active Crohn's disease
- Treatment of ulcerative colitis and rheumatoid arthritis
- Treatment of ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis
infliximab-dyyb side effects
The following side effects have been reported for infliximab-dyyb. Their order does not indicate how often an effect occurs.
infliximab-dyyb warnings & precautions
- Risk of serious infections including tuberculosis; screen before starting treatment
- Increased risk of lymphoma and other malignancies
Loading FDA data…
Frequently asked questions
Related medications
Share this drug info.
Help friends and family understand INFLECTRA in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.